BOEHRINGER INGELHEIM INTERNATIONAL GMBH;VITAE PHARMACEUTICALS, INC.
发明人:
COLIN M. TICE,DAVID A. CLAREMON,FRANK HIMMELSBACH,KATERINA LEFTHERIS,LINGHANG ZHUANG,SALVACION CACATIAN,SURESH B. SINGH,WEI ZHAO,YUANJIE YE,ZHENRONG XU
申请号：
BRPI0911764
公开号：
BRPI0911764A2
申请日:
2009.04.30
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
Disclosed is a compound represented by Formula (Im1) or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof. Also disclosed are pharmaceutical compositions comprising the compound of Formula (Im1) or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof and methods of inhibiting 11&bgr；-HSD1 activity comprising the step of administering to a mammal in need of such treatment an effective amount of a compound of Formulas (Im1), or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.
